WordNet

a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
the state of the environment in which a situation exists; "you cant do that in a university setting" (同)background, scope
the context and environment in which something is set; "the perfect setting for a ghost story" (同)scene
the physical position of something; "he changed the setting on the thermostat"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"

PrepTutorEJDIC

『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈C〉(宝石などの)はめこみ台 / 〈C〉(劇・文学作品り)背景・舞台 / 〈C〉(劇の)舞台装置,道真立て / 〈C〉(一般に)環境,境遇 / 〈U〉〈C〉(物語・詩などにつけられた)曲 / 〈C〉(卵の)一かえり,一抱き / 〈U〉すえつけること,置くこと;(日・月の)入り / 〈C〉一分の食器類
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Ratiometric biosensor array for multiplexed detection of microRNAs based on electrochemiluminescence coupled with cyclic voltammetry.

Feng X1, Gan N1, Zhang H1, Li T1, Cao Y1, Hu F2, Jiang Q3.
Biosensors & bioelectronics.Biosens Bioelectron.2016 Jan 15;75:308-14. doi: 10.1016/j.bios.2015.08.048. Epub 2015 Aug 28.
A novel multiplexed ratiometric biosensor array was fabricated on a homemade screen-printed carbon electrode (SPCE) for near-simultaneous detection of microRNA (miRNA)-21 and miRNA-141 based on electrochemiluminescence (ECL) coupled with cyclic voltammetry (CV) method. In the detection system, the E
PMID 26332383

Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.

Dal Bello MG1, Alama A1, Barletta G1, Coco S1, Truini A1,2, Vanni I1, Boccardo S3, Genova C1, Rijavec E1, Biello F1, Bottoni G4, Sambuceti G4, Grossi F1.
International journal of cancer. Journal international du cancer.Int J Cancer.2015 Dec 15;137(12):2947-58. doi: 10.1002/ijc.29647. Epub 2015 Jul 15.
Preclinical studies have suggested that combining cytotoxic agents with epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) to treat EGFR-mutated tumors may increase their inhibitory effect depending on the order of drug administration. The antitumor efficacy of different treatme
PMID 26089022

Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013-2015.

Cenciarelli O1, Gabbarini V2, Pietropaoli S3, Malizia A4, Tamburrini A2, Ludovici GM2, Carestia M4, Di Giovanni D4, Sassolini A5, Palombi L6, Bellecci C4, Gaudio P4.
Virus research.Virus Res.2015 Dec 2;210:318-26. doi: 10.1016/j.virusres.2015.09.002. Epub 2015 Sep 8.
Among the potential biological agents suitable as a weapon, Ebola virus represents a major concern. Classified by the CDC as a category A biological agent, Ebola virus causes severe hemorrhagic fever, characterized by high case-fatality rate; to date, no vaccine or approved therapy is available. The
PMID 26359111

Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists

Efficacy and safety assessment of basal supported oral therapy (BOT) with insulin glargine in a real-life clinical setting, stratified by concomitant orally administered antidiabetic agent (OAD) regimens including dipeptidyl peptidase-4 inhibitor (DPP-4i) : subanalysis of the ALOHA2 study, drug-use surveillance in Japan